Cite
Olaratumab in soft tissue sarcoma - Current status and future perspectives.
MLA
Antoniou, Georgios, et al. “Olaratumab in Soft Tissue Sarcoma - Current Status and Future Perspectives.” European Journal of Cancer (Oxford, England : 1990), vol. 92, Mar. 2018, pp. 33–39. EBSCOhost, https://doi.org/10.1016/j.ejca.2017.12.026.
APA
Antoniou, G., Lee, A. T. J., Huang, P. H., & Jones, R. L. (2018). Olaratumab in soft tissue sarcoma - Current status and future perspectives. European Journal of Cancer (Oxford, England : 1990), 92, 33–39. https://doi.org/10.1016/j.ejca.2017.12.026
Chicago
Antoniou, Georgios, Alexander T J Lee, Paul H Huang, and Robin L Jones. 2018. “Olaratumab in Soft Tissue Sarcoma - Current Status and Future Perspectives.” European Journal of Cancer (Oxford, England : 1990) 92 (March): 33–39. doi:10.1016/j.ejca.2017.12.026.